SPY367.55+0.76 0.21%
DIA300.67+1.49 0.50%
IXIC12,419.92+70.55 0.57%

Morgan Stanley Maintains Overweight on Inari Medical, Raises Price Target to $85

Morgan Stanley maintains Inari Medical (NASDAQ:NARI) with a Overweight and raises the price target from $76 to $85.

· 11/13/2020 07:55
Morgan Stanley maintains Inari Medical (NASDAQ:NARI) with a Overweight and raises the price target from $76 to $85.